{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T17:09:32Z","timestamp":1760980172716,"version":"3.40.3"},"reference-count":59,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":3864,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2005,2]]},"DOI":"10.1002\/lt.20353","type":"journal-article","created":{"date-parts":[[2005,1,21]],"date-time":"2005-01-21T17:47:06Z","timestamp":1106329626000},"page":"124-133","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":8,"title":["Management of pre-liver transplantation patients\u2014Part 1"],"prefix":"10.1097","volume":"11","author":[{"given":"Pratima","family":"Sharma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Rakela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-2-20250326","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/lt.500060122","article-title":"Liver transplantation. American Association for the Study of Liver Diseases.","volume":"6","author":"Carithers","year":"2000","journal-title":"Liver Transpl"},{"key":"R3-2-20250326","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1002\/lt.500030613","article-title":"Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases.","volume":"3","author":"Lucey","year":"1997","journal-title":"Liver Transpl Surg"},{"key":"R5-2-20250326","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1053\/jhep.2001.22172","article-title":"A model to predict survival in patients with endstage liver disease.","volume":"33","author":"Kamath","year":"2001","journal-title":"Hepatology"},{"key":"R6-2-20250326","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1053\/jlts.2001.25879","article-title":"MELD and PELD: application of survival models to liver allocation.","volume":"7","author":"Wiesner","year":"2001","journal-title":"Liver Transpl"},{"key":"R7-2-20250326","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1053\/he.2000.5852","article-title":"A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts.","volume":"31","author":"Malinchoc","year":"2000","journal-title":"Hepatology"},{"key":"R8-2-20250326","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-230X-2-2","article-title":"Utility of the Mayo endstage liver disease (MELD) score in assessing prognosis of patients with alcoholic hepatitis.","volume":"2","author":"Sheth","year":"2002","journal-title":"BMC Gastroenterol"},{"key":"R9-2-20250326","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJM199603143341104","article-title":"Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis.","volume":"334","author":"Mazzaferro","year":"1996","journal-title":"N Engl J Med"},{"key":"R10-2-20250326","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1002\/hep.510250540","article-title":"Hepatopulmonary syndrome versus portopulmonary hypertension: distinctions and dilemmas.","volume":"25","author":"Krowka","year":"1997","journal-title":"Hepatology"},{"key":"R11-2-20250326","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1053\/jlts.2000.6356","article-title":"Pulmonary hemodynamics and perioperative cardiopulmonaryrelated mortality in patients with portopulmonary hypertension undergoing liver transplantation.","volume":"6","author":"Krowka","year":"2000","journal-title":"Liver Transpl"},{"key":"R12-2-20250326","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1053\/jhep.2002.30318","article-title":"Obesity and its effect on survival in patients undergoing orthotopic liver transplantation in the United States.","volume":"35","author":"Nair","year":"2002","journal-title":"Hepatology"},{"key":"R14-2-20250326","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1097\/00007890-199808270-00015","article-title":"Age and liver transplantation: a report of the Liver Transplantation Database.","volume":"66","author":"Zetterman","year":"1998","journal-title":"Transplantation"},{"key":"R15-2-20250326","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/00000658-200101000-00016","article-title":"The elderly liver transplant recipient: a call for caution.","volume":"233","author":"Levy","year":"2001","journal-title":"Ann Surg"},{"key":"R17-2-20250326","first-page":"506","article-title":"Successful liver transplantation in a patient with a thrombosed portomesenteric system after multiple failed shunts.","volume":"86","author":"Castaldo","year":"1991","journal-title":"Am J Gastroenterol"},{"key":"R19-2-20250326","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1001\/archsurg.1989.01410080025003","article-title":"Stratifying the causes of death in liver transplant recipients. An approach to improving survival.","volume":"124","author":"Shaw","year":"1989","journal-title":"Arch Surg"},{"key":"R20-2-20250326","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1016\/S0140-6736(00)03232-3","article-title":"Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study.","volume":"356","author":"Greub","year":"2000","journal-title":"Lancet"},{"key":"R21-2-20250326","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0168-8278(97)80001-3","article-title":"Human immunodeficiency virus infection modifies the natural history of chronic parenterallyacquired hepatitis C with an unusually rapid progression to cirrhosis.","volume":"26","author":"Soto","year":"1997","journal-title":"J Hepatol"},{"key":"R22-2-20250326","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/BF01691375","article-title":"Influence of human immunodeficiency virus type 1 infection on the natural course of chronic parenterally acquired hepatitis C.","volume":"14","author":"SanchezQuijano","year":"1995","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R23-2-20250326","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1086\/318501","article-title":"Increasing mortality due to endstage liver disease in patients with human immunodeficiency virus infection.","volume":"32","author":"Bica","year":"2001","journal-title":"Clin Infect Dis"},{"key":"R24-2-20250326","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1023\/A:1007506617734","article-title":"Impact of chronic liver disease due to hepatitis viruses as cause of hospital admission and death in HIVinfected drug users.","volume":"15","author":"Soriano","year":"1999","journal-title":"Eur J Epidemiol"},{"key":"R25-2-20250326","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/00002030-200101260-00029","article-title":"Liver transplantation for an HIVpositive patient in the era of highly active antiretroviral therapy.","volume":"15","author":"Gow","year":"2001","journal-title":"Aids"},{"key":"R26-2-20250326","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1086\/379254","article-title":"Survival of human immunodeficiency virusinfected liver transplant recipients.","volume":"188","author":"Ragni","year":"2003","journal-title":"J Infect Dis"},{"key":"R27-2-20250326","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1053\/jlts.2003.50054","article-title":"Orthotopic liver transplantation in patients with human immunodeficiency virus and endstage liver disease.","volume":"9","author":"Neff","year":"2003","journal-title":"Liver Transpl"},{"key":"R28-2-20250326","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1056\/NEJMsb020632","article-title":"Solidorgan transplantation in HIVinfected patients.","volume":"347","author":"Halpern","year":"2002","journal-title":"N Engl J Med"},{"key":"R29-2-20250326","doi-asserted-by":"crossref","first-page":"S74","DOI":"10.1002\/hep.1840360710","article-title":"Hepatocellular carcinoma and hepatitis C in the United States.","volume":"36","author":"ElSerag","year":"2002","journal-title":"Hepatology"},{"key":"R30-2-20250326","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1002\/hep.1840380430","article-title":"MRI angiography is superior to helical CT for detection of HCC prior to liver transplantation: an explant correlation.","volume":"38","author":"Burrel","year":"2003","journal-title":"Hepatology"},{"key":"R31-2-20250326","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1056\/NEJM199801293380503","article-title":"Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C.","volume":"338","author":"Vento","year":"1998","journal-title":"N Engl J Med"},{"issue":"Suppl","key":"R32-2-20250326","first-page":"S17","article-title":"The importance and benefits of hepatitis A prevention in chronic liver disease patients.","volume":"19","author":"Cooksley","year":"2004","journal-title":"J Gastroenterol Hepatol"},{"key":"R33-2-20250326","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/j.1365-2036.2004.01906.x","article-title":"Review article: hepatitis vaccination in patients with chronic liver disease.","volume":"19","author":"Reiss","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"R34-2-20250326","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1053\/jlts.2000.8313","article-title":"Vaccination against hepatitis B virus in cirrhotic patients on liver transplant waiting list.","volume":"6","author":"Dominguez","year":"2000","journal-title":"Liver Transpl"},{"issue":"Suppl B","key":"R35-2-20250326","doi-asserted-by":"crossref","first-page":"59B","DOI":"10.1155\/2000\/548206","article-title":"Ineffectiveness of hepatitis B vaccination in cirrhotic patients waiting for liver transplantation.","volume":"14","author":"Villeneuve","year":"2000","journal-title":"Can J Gastroenterol"},{"key":"R36-2-20250326","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1053\/jlts.2001.23069","article-title":"Doubledose accelerated hepatitis B vaccine in patients with endstage liver disease.","volume":"7","author":"Arslan","year":"2001","journal-title":"Liver Transpl"},{"key":"R37-2-20250326","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1053\/jlts.2002.32983","article-title":"Effect of lamivudine treatment on survival of 309 North American patients awaiting liver transplantation for chronic hepatitis B.","volume":"8","author":"Fontana","year":"2002","journal-title":"Liver Transpl"},{"key":"R38-2-20250326","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1053\/jhep.2000.19622","article-title":"Evolution of hepatitis B virus polymerase gene mutations in hepatitis B e antigennegative patients receiving lamivudine therapy.","volume":"32","author":"Lok","year":"2000","journal-title":"Hepatology"},{"key":"R39-2-20250326","first-page":"1419","article-title":"Adefovir dipivoxil therapy for lamivudineresistant hepatitis B in pre and postliver transplantation patients.","volume":"38","author":"Schiff","year":"2003","journal-title":"Hepatology"},{"key":"R40-2-20250326","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1002\/hep.20119","article-title":"Diagnosis, management, and treatment of hepatitis C.","volume":"39","author":"Strader","year":"2004","journal-title":"Hepatology"},{"key":"R41-2-20250326","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJMoa020047","article-title":"Peginterferon alfa2a plus ribavirin for chronic hepatitis C virus infection.","volume":"347","author":"Fried","year":"2002","journal-title":"N Engl J Med"},{"key":"R42-2-20250326","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1053\/jhep.2001.24783","article-title":"Diagnosis and management of hemochromatosis.","volume":"33","author":"Tavill","year":"2001","journal-title":"Hepatology"},{"key":"R43-2-20250326","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1053\/gast.1996.v110.pm8613000","article-title":"Longterm survival in patients with hereditary hemochromatosis.","volume":"110","author":"Niederau","year":"1996","journal-title":"Gastroenterology"},{"key":"R44-2-20250326","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/hep.510250130","article-title":"The relationship between iron overload, clinical symptoms, and age in 410 patients with genetic hemochromatosis.","volume":"25","author":"Adams","year":"1997","journal-title":"Hepatology"},{"key":"R45-2-20250326","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/S0016-5085(97)70183-5","article-title":"Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis.","volume":"113","author":"Poupon","year":"1997","journal-title":"Gastroenterology"},{"key":"R46-2-20250326","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1056\/NEJM199703063361003","article-title":"Ursodiol for primary sclerosing cholangitis. Mayo Primary Sclerosing CholangitisUrsodeoxycholic Acid Study Group.","volume":"336","author":"Lindor","year":"1997","journal-title":"N Engl J Med"},{"key":"R47-2-20250326","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1053\/he.2000.5984","article-title":"Management of primary biliary cirrhosis. The American Association for the Study of Liver Diseases practice guidelines.","volume":"31","author":"Heathcote","year":"2000","journal-title":"Hepatology"},{"key":"R48-2-20250326","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0016-5085(00)70423-9","article-title":"Vitamin Dreceptor genotypes as independent genetic predictors of decreased bone mineral density in primary biliary cirrhosis.","volume":"118","author":"Springer","year":"2000","journal-title":"Gastroenterology"},{"issue":"Suppl 1","key":"R49-2-20250326","doi-asserted-by":"crossref","first-page":"i1","DOI":"10.1136\/gut.50.suppl_1.i1","article-title":"Guidelines on the management of osteoporosis associated with chronic liver disease.","volume":"50","author":"Collier","year":"2002","journal-title":"Gut"},{"key":"R50-2-20250326","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1572-0241.2000.01685.x","article-title":"The utility of CA 19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitis.","volume":"95","author":"Patel","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"R51-2-20250326","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/0016-5085(95)90462-X","article-title":"Serum tumor markers for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis.","volume":"108","author":"Ramage","year":"1995","journal-title":"Gastroenterology"},{"key":"R52-2-20250326","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0168-8278(99)80198-6","article-title":"A 3year prospective study on serum tumor markers used for detecting cholangiocarcinoma in patients with primary sclerosing cholangitis.","volume":"30","author":"Hultcrantz","year":"1999","journal-title":"J Hepatol"},{"issue":"Suppl 6","key":"R53-2-20250326","first-page":"VI1","article-title":"Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document.","volume":"51","author":"Khan","year":"2002","journal-title":"Gut"},{"key":"R54-2-20250326","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3109\/00365529409103626","article-title":"Ursodeoxycholic acid therapy in treatment of primary sclerosing cholangitis.","volume":"204","author":"Stiehl","year":"1994","journal-title":"Scand J Gastroenterol Suppl"},{"key":"R55-2-20250326","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1053\/gast.1996.v110.pm8566577","article-title":"Risk and natural history of colonic neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis.","volume":"110","author":"Brentnall","year":"1996","journal-title":"Gastroenterology"},{"key":"R56-2-20250326","doi-asserted-by":"crossref","first-page":"89","DOI":"10.7326\/0003-4819-134-2-200101160-00008","article-title":"Ursodiol use is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis.","volume":"134","author":"Tung","year":"2001","journal-title":"Ann Intern Med"},{"key":"R57-2-20250326","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1055\/s-2002-35706","article-title":"Treatment of autoimmune hepatitis.","volume":"22","author":"Czaja","year":"2002","journal-title":"Semin Liver Dis"},{"key":"R58-2-20250326","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1034\/j.1600-0641.2000.033004609.x","article-title":"The impact of liver disease and medical complications on quality of life and psychological distress before and after liver transplantation.","volume":"33","author":"De Bona","year":"2000","journal-title":"J Hepatol"},{"key":"R59-2-20250326","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1023\/A:1018898106656","article-title":"Depression in patients with cirrhosis. Impact on outcome.","volume":"42","author":"Singh","year":"1997","journal-title":"Dig Dis Sci"},{"issue":"Suppl 1","key":"R60-2-20250326","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0168-8278(21)80004-5","article-title":"Malnutrition in cirrhosis.","volume":"23","author":"Muller","year":"1995","journal-title":"J Hepatol"},{"key":"R61-2-20250326","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1093\/ajcn\/69.2.331","article-title":"Influence of the metabolic sequelae of liver cirrhosis on nutritional intake.","volume":"69","author":"Richardson","year":"1999","journal-title":"Am J Clin Nutr"},{"key":"R62-2-20250326","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/00075197-199907000-00017","article-title":"Liver cirrhosis: rationale and modalities for nutritional supportthe European Society of Parenteral and Enteral Nutrition consensus and beyond.","volume":"2","author":"Lochs","year":"1999","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"R63-2-20250326","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1007\/BF01307509","article-title":"Shortterm oral zinc supplementation does not improve chronic hepatic encephalopathy. Results of a doubleblind crossover trial.","volume":"36","author":"Riggio","year":"1991","journal-title":"Dig Dis Sci"},{"key":"R64-2-20250326","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S0899-9007(98)00191-9","article-title":"Nutritional support in hepatic encephalopathy.","volume":"15","author":"Mizock","year":"1999","journal-title":"Nutrition"}],"container-title":["Liver Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Flt.20353","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01445473-200502000-00002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T14:24:58Z","timestamp":1743258298000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01445473-200502000-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2]]},"references-count":59,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005]]}},"URL":"https:\/\/doi.org\/10.1002\/lt.20353","relation":{},"ISSN":["1527-6465"],"issn-type":[{"type":"print","value":"1527-6465"}],"subject":[],"published":{"date-parts":[[2005,2]]}}}